English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Rheumatoid arthritis (RA) is a systemic disease affecting mainly joints. Since rheumatoid arthritis is a common and a world wide problem therefore accurate diagnosis of this disease is essential. In the past rheumatoid factor was considered as the only marker for diagnosing this disease; however rheumatoid factor is present in many other disorders and even in up to 15% of healthy population. For the detection of rheumatoid arthritis, over the years many auto antibodies have been reported such as anti perinuclear factor (APF) and anti keratin antibodies (AKA) but they were not specifi c and due to the tedious procedure used for their laboratory diagnosis, they could not become popular for the diagnosis of this disease. Recently anti-CCP antibodies have been reported and they are becoming popular due to their high sensitivity and specifi city. It is hoped that in a couple of years time anti-CCP antibodies could be included in the ACR criteria for diagnosing RA. KEYWORDS: Rheumatoid factor, anti perinuclear factor, anti keratin antibodies, anti-cyclic citrullinated peptide antibodies

Anti-CCP Antibodies: an Emerging Marker for the Early Diagnosis of Rheumatoid Arthritis